期刊文献+

胰腺癌姑息性治疗方法初探 被引量:5

Explore of Palliative Treatment for Pancreatic Carcinoma
下载PDF
导出
摘要 目的探讨胰腺癌姑息性治疗方法的选择及其对生存期的影响。方法对近3年来54例行姑息性治疗的胰腺癌患者的临床资料进行回顾性分析。结果行胆肠吻合术+全身化疗(S+C)18例,胆肠吻合术+动脉灌注化疗(S+A)19例,胆肠吻合术+动脉灌注化疗+放疗(S+A+R)17例。行S+A+R组患者生存期显著长于前两组(P<0.05),且疼痛缓解明显。结论姑息性手术+区域动脉灌注化疗+放疗可以延长晚期胰腺癌患者的生存期及改善生存质量。 Objective To explore the selection of palliative therapy for pancreatic carcinoma and the effects on the survival time. Methods Clinical data of cases of pancreatic carcinoma with palliative therapy in recent 3 years were analyzed retrospectively. Results 18 cases were with chol - intestinal anastomosis plus general chemotherapy( S + C), 19 cases with chol - intestinal anastomosis plus arterial perfusion chemotherapy (S + A), and 17 cases with chol - intestinal anastomosis plus arterial perfusion chemotherapy plus radiotherapy ( S + A + R). The survival time of patients in the ( S + A + R) group was longer than that in other two groups (P 〈 0.05 ). The relieve pain in the ( S + A + R) group was obviously. Conclusions The palliative operation plus regional arterial perfusion chemotherapy plus radiotherapy will prolong the survival time of the patients with pancreatic carcinoma in advanced stage and improve life quality.
出处 《实用全科医学》 2007年第1期27-28,共2页 Applied Journal Of General Practice
关键词 胰腺肿瘤 姑息性治疗 Pancreatic carcinoma Palliative therapy
  • 相关文献

参考文献3

  • 1张跃,华积德.不可切除性胰腺癌的姑息性治疗现状[J].肝胆外科杂志,2000,8(6):477-480. 被引量:1
  • 2刘泰福主编..现代放射肿瘤学[M].上海:复旦大学出版社;上海医科大学出版社,2001:607.
  • 3George P. Schelling M.D.,Rene P. Bosch M.D.,Jean H. G. Klinkenbij M.D.,Paul G. H. Mulder M.Sc.,Johannes Jeekel M.D., Ph.D.. Is there a place for gastroenterostomy in patients with advanced cancer of the head of the pancreas?[J] 1993,World Journal of Surgery(1):128~132 被引量:1

二级参考文献26

  • 1[1]Baumel H,Huguier M,Manderscheid JC,et al.Results of resection for cancer of the exocrine pancreas:a study from the French Association of Surgery.Br J Surg,1994,81:102. 被引量:1
  • 2[2]Niederhuber JE,Brennan MF,menck HR.The national cancer data base report on pancreatic cancer.Cancer,1995,76:1 671. 被引量:1
  • 3[3]Conlon KC,Klimstra DS,Brennan MF.Long-term survival after curative resection for pancreatic ductal adenocarcinoma.Clinicopathologic analysis of 5 year survivors.Ann Surg,1996,223:273. 被引量:1
  • 4[4]Sperti C,Pasquali C,Piccoli A,et al.Survival after resection for ductal adenocarcinoma of the pancreas.Br J Surg,1996,83:625. 被引量:1
  • 5[5]Burris HA,Moore MT,Andersen J,et al.Improvements in survival and clinical benefit with gemcitabine as first-line-therapy for patients with advanced pancreatic cancer:a randomized trial.J Clin Oncol,1997,15:2 403. 被引量:1
  • 6[6]Abrams RA,Grochow,LB.Adjuvant therapy with chemotherapy and radiation therapy in the management of carcinoma of the pancreatic head.Surg Clin North Am,1995,75:925. 被引量:1
  • 7[7]Huguier M,Samama G,Testart J,et al.From the French Association for Surgical Research:treatment of adenocarcinoma of the pancreas with somatostatin and gonadoliberin(luteinizing hormone-releasing hormone).Am J Surg,1992,164:348. 被引量:1
  • 8[8]Andren-Sandberg A,Backman PL.Hormonal therapy and immunotherapy.In:Howard JM,Idezuki Y,Ihse I,Prinz RA,editors.Surgical diseases of the pancreas.3rd ed,Baltimore (MD):Williams and Wilkens,1998:613. 被引量:1
  • 9[9]Abbruzzese JL,Gholson CF,Daugherty k,et al.A pilot clinical trial of the cholecystokinin receptor antagonist MK-329 in patients with advanced pancreatic cancer.Pancreas,1992,7:165. 被引量:1
  • 10[10]Bakkevold KE,Pattersen A,Arnesjo B,et al.Tamoxifen therapy in unresectable adenocarcinoma of the pancreas and the papilla of Vater.Br J Surg,1990,77:725. 被引量:1

同被引文献44

引证文献5

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部